Biotech · Private company · Philadelphia, PA, US
Integral Molecular
Track this companyFree. Adds Integral Molecular to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards10
- High-throughput Discovery of Antibodies against Understudied Membrane Proteins using mRNAFiscal year 2026 · $631KNIH RePORTER 5R44GM150317-03 · fetched Nov 12, 2026
- Specificity Screening Drug Development Tool for Biotherapeutic SafetyFiscal year 2026 · $879.3KNIH RePORTER 5SB1GM156044-03 · fetched Nov 12, 2026
- Generation of Pan-reactive Antibody and Cytokine Reagents for Immunologic Analysis of BatsFiscal year 2026 · $541.9KNIH RePORTER 5U24AI189369-02 · fetched Nov 12, 2026
- B cell Epitope Discovery and Mechanisms of Antibody Protection for Enterovirus and Bunyavirus Entry ProteinsFiscal year 2026 · $1.6MNIH RePORTER 75N93024C00071-P00003-9999-1 · fetched Nov 12, 2026
- Generation of Pan-reactive Antibody and Cytokine Reagents for Immunologic Analysis of BatsFiscal year 2025 · $495.1KNIH RePORTER 1U24AI189369-01 · fetched Nov 12, 2026
- High-throughput Discovery of Antibodies against Understudied Membrane Proteins using mRNAFiscal year 2025 · $923.1KNIH RePORTER 2R44GM150317-02 · fetched Nov 12, 2026
- Development of Safe and Rapid Reporter Viruses for Studying Pathogenic and Pandemic VirusesFiscal year 2025 · $288.5KNIH RePORTER 5R43AI186556-02 · fetched Nov 12, 2026
- Specificity Screening Drug Development Tool for Biotherapeutic SafetyFiscal year 2025 · $929KNIH RePORTER 5SB1GM156044-02 · fetched Nov 12, 2026
- B cell Epitope Discovery and Mechanisms of Antibody Protection for Enterovirus and Bunyavirus Entry ProteinsFiscal year 2025 · $1.7MNIH RePORTER 75N93024C00071-P00001-9999-1 · fetched Nov 12, 2026
- ANTIBODY REAGENTS FOR IMMUNOLOGIC ANALYSIS OF UNDER-REPRESENTED MAMMALIAN MODELSFiscal year 2025 · $1.5MNIH RePORTER 75N93025C00019-0-9999-1 · fetched Nov 12, 2026